Institutional investors purchased a net $3.5 million shares of RGEN during the quarter ended September 2013, and now own 73.98% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ACADIAN ASSET MANAGEMENT LLC Bought 1.1 Million shares of Repligen Corp
KALMAR INVESTMENTS, INC. Bought 925.0 Thousand shares of Repligen Corp
BLACKROCK ADVISORS LLC Bought 370.4 Thousand shares of Repligen Corp